Kevin T. Mellem, Ph.D. - Publications

Affiliations: 
2013 Chemistry and Chemical Biology Harvard University, Cambridge, MA, United States 
Area:
synthesis of natural products

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Koltun ES, Aay N, Buckl A, Jogalekar AS, Kiss G, Marquez A, Mellem KT, Mordec K, Saldajeno-Concar M, Semko CM, Tibrewal N, Tzitzilonis C, Won W, Smith JA, Wilson SE, et al. Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity Cancer Research. 78: 4878-4878. DOI: 10.1158/1538-7445.Am2018-4878  0.301
2013 Mellem KT, Myers AG. A simple, scalable synthetic route to (+)- and (-)-pseudoephenamine. Organic Letters. 15: 5594-7. PMID 24138164 DOI: 10.1021/Ol402815D  0.528
2013 Hugelshofer CL, Mellem KT, Myers AG. Synthesis of quaternary α-methyl α-amino acids by asymmetric alkylation of pseudoephenamine alaninamide pivaldimine. Organic Letters. 15: 3134-7. PMID 23746325 DOI: 10.1021/Ol401337P  0.497
2012 Morales MR, Mellem KT, Myers AG. Pseudoephenamine: a practical chiral auxiliary for asymmetric synthesis. Angewandte Chemie (International Ed. in English). 51: 4568-71. PMID 22461381 DOI: 10.1002/Anie.201200370  0.536
2012 Morales MR, Mellem KT, Myers AG. ChemInform Abstract: Pseudoephenamine: A Practical Chiral Auxiliary for Asymmetric Synthesis. Cheminform. 43: no-no. DOI: 10.1002/chin.201238022  0.535
Show low-probability matches.